102 related articles for article (PubMed ID: 27630294)
1. Altered Expression of PRKX, WNT3 and WNT16 in Human Nodular Basal Cell Carcinoma.
DO Carmo NG; Sakamoto LH; Pogue R; DO Couto Mascarenhas C; Passos SK; Felipe MS; DE Andrade RV
Anticancer Res; 2016 Sep; 36(9):4545-51. PubMed ID: 27630294
[TBL] [Abstract][Full Text] [Related]
2. Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.
Yu M; Zloty D; Cowan B; Shapiro J; Haegert A; Bell RH; Warshawski L; Carr N; McElwee KJ
J Invest Dermatol; 2008 Jul; 128(7):1797-805. PubMed ID: 18200053
[TBL] [Abstract][Full Text] [Related]
3. Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.
Shi FT; Yu M; Zloty D; Bell RH; Wang E; Akhoundsadegh N; Leung G; Haegert A; Carr N; Shapiro J; McElwee KJ
Mol Med Rep; 2017 Apr; 15(4):1441-1454. PubMed ID: 28259916
[TBL] [Abstract][Full Text] [Related]
4. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.
O'Driscoll L; McMorrow J; Doolan P; McKiernan E; Mehta JP; Ryan E; Gammell P; Joyce H; O'Donovan N; Walsh N; Clynes M
Mol Cancer; 2006 Dec; 5():74. PubMed ID: 17173689
[TBL] [Abstract][Full Text] [Related]
6. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
7. Pattern of mRNA expression of beta-defensins in basal cell carcinoma.
Gambichler T; Skrygan M; Huyn J; Bechara FG; Sand M; Altmeyer P; Kreuter A
BMC Cancer; 2006 Jun; 6():163. PubMed ID: 16796735
[TBL] [Abstract][Full Text] [Related]
8. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
[TBL] [Abstract][Full Text] [Related]
9. G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation.
Tanese K; Fukuma M; Yamada T; Mori T; Yoshikawa T; Watanabe W; Ishiko A; Amagai M; Nishikawa T; Sakamoto M
Am J Pathol; 2008 Sep; 173(3):835-43. PubMed ID: 18688030
[TBL] [Abstract][Full Text] [Related]
10. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
11. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
[TBL] [Abstract][Full Text] [Related]
12. Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma.
Noubissi FK; Yedjou CG; Spiegelman VS; Tchounwou PB
Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 29987229
[TBL] [Abstract][Full Text] [Related]
13. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
[TBL] [Abstract][Full Text] [Related]
14. Discordant expression of desmoglein 2 and 3 at the mRNA and protein levels in nodular and superficial basal cell carcinoma revealed by immunohistochemistry and fluorescent in situ hybridization.
Pietkiewicz P; Gornowicz-Porowska J; Bowszyc-Dmochowska M; Jagielska J; Helak-Łapaj C; Kaczmarek E; Dmochowski M
Clin Exp Dermatol; 2014 Jul; 39(5):628-35. PubMed ID: 24934917
[TBL] [Abstract][Full Text] [Related]
15. RUNX3 protein is overexpressed in human basal cell carcinomas.
Salto-Tellez M; Peh BK; Ito K; Tan SH; Chong PY; Han HC; Tada K; Ong WY; Soong R; Voon DC; Ito Y
Oncogene; 2006 Dec; 25(58):7646-9. PubMed ID: 16767156
[TBL] [Abstract][Full Text] [Related]
16. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
[TBL] [Abstract][Full Text] [Related]
17. Differential expression patterns of metastasis suppressor proteins in basal cell carcinoma.
Bozdogan O; Yulug IG; Vargel I; Cavusoglu T; Karabulut AA; Karahan G; Sayar N
Int J Dermatol; 2015 Aug; 54(8):905-15. PubMed ID: 25428551
[TBL] [Abstract][Full Text] [Related]
18. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
[TBL] [Abstract][Full Text] [Related]
19. Role of CRD-BP in the growth of human basal cell carcinoma cells.
Noubissi FK; Kim T; Kawahara TN; Aughenbaugh WD; Berg E; Longley BJ; Athar M; Spiegelman VS
J Invest Dermatol; 2014 Jun; 134(6):1718-1724. PubMed ID: 24468749
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
Bartoš V; Kullová M
Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
